Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Open-source antibodies as a path to enhanced research reproducibility and transparency

New Biotechnology(2025)10.1016/j.nbt.2025.04.004Source: DataRank Database

Open-source antibodies as a path to enhanced research reproducibility and transparency is a research paper published in New Biotechnology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.20)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Douglas W. Houston ORCID,Melina Fan ORCID,Karl D. Murray ORCID,James S Trimmer ORCID,Meghan A. Rego ORCID

Live enrichment

PubMed:40252918 PMC:PMC12183686 OpenAlex:https://openalex.org/W4409534650

National Institute of Neurological Disorders and Stroke

Grant: U24 NS109113

National Institute of Neurological Disorders and Stroke

Grant: U24 NS119916

National Institutes of Health

University of California, Davis

National Cancer Institute

FWCI

5.20

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.nbt.2025.04.004

publisherhttps://doi.org/10.1016/j.nbt.2025.04.004

publisherhttps://api.elsevier.com/content/article/PII:S1871678425000421?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1871678425000421?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40252918

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical MethodsCAR-T cell therapy research

MeSH Terms

AnimalsAntibodiesHumansSoftwareReproducibility of ResultsBiomedical Research

Keywords

Transparency (behavior)ReproducibilityChemistryComputer scienceChromatographyComputer securityMonoclonal antibodyPlasmidHybridomaRecombinant AntibodyResearch ResourceResearch Reproducibility And Transparency

Sustainable Development Goals

SDG 0: Gender equality

Open-source antibodies as a path to enhanced research reproducibility and transparency

FAIR Checklist

Authors (5)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)